Arix Bioscience — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Velosbiovelosbio.comin𝕏Aug 2026
A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.
BiotechSan Diego, US
David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in
Co-investorsChiesi VenturesPappas CapitalSofinnova VenturesVedanta CapitalOrbiMed
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.